GO:0071040 nuclear polyadenylation-dependent antisense transcript catabolic process

GO:0071040, nuclear polyadenylation-dependent antisense transcript catabolic process, is a biological process that occurs in the nucleus and results in the breakdown of antisense transcripts after they receive a poly(A) tail. Antisense transcripts are RNAs that are complementary to sense transcripts and can regulate gene expression; their controlled removal is essential for nuclear RNA homeostasis. The process is initiated by enzymatic addition of adenylyl residues to the 3' end of the target antisense transcript, which marks it for degradation. This term is part of the Gene Ontology's biological_process aspect and is also known as nuclear poly(A)-dependent antisense transcript catabolic process. Researchers study GO:0071040 because it sits at the intersection of RNA processing, nuclear surveillance, and gene regulation. Defects in polyadenylation-dependent decay can allow antisense transcripts to accumulate, potentially interfering with sense gene expression and contributing to disease. The pathway has been characterized in systems where polyadenylation acts as a signal for RNA degradation, including human mitochondrial RNA metabolism. Understanding this process helps explain how cells distinguish functional RNAs from those destined for destruction. From a methods perspective, GO:0071040 can be interrogated with transcriptome-wide approaches that capture poly(A) site usage, antisense transcript levels, and decay intermediates. CRISPR-based models allow researchers to remove or modify candidate decay factors and observe the consequences on antisense RNA stability. This article summarizes the definition, mechanism, key genes, disease links, and experimental strategies for studying this process.

In simple terms, GO:0071040 is the nuclear process where an antisense RNA gets a poly(A) tail added and is then broken down. More formally, it encompasses the chemical reactions and pathways occurring in the nucleus that result in the breakdown of an antisense transcript, initiated by enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end of the target antisense transcript. The synonym nuclear poly(A)-dependent antisense transcript catabolic process reflects the same concept.

GO:0071040 is important because it defines a nuclear quality-control route that uses polyadenylation as a degradation signal for antisense transcripts. This process helps prevent the accumulation of potentially disruptive antisense RNAs and maintains the balance between sense and antisense transcription. Because polyadenylation can either stabilize or destabilize RNAs depending on context, studying this term clarifies how cells assign different fates to transcripts. Insights into this pathway are relevant to RNA biology, gene regulation, and diseases involving defective RNA turnover.

The following genes and proteins have been implicated in polyadenylation-dependent RNA decay and related nuclear surveillance processes, based on published literature.

The process is regulated by the availability and activity of polyadenylation and degradation factors, as well as by signals that mark antisense transcripts for turnover. In human mitochondria, polyadenylation and degradation are coordinated to maintain RNA homeostasis, and disruptions in this balance can lead to disease. Regulation may also involve RNA-binding proteins that recognize antisense features and recruit decay machinery.

Defects in polyadenylation-dependent RNA degradation have been linked to mitochondrial dysfunction, as polyadenylation and degradation of human mitochondrial RNA are essential for proper mitochondrial gene expression. Mutations in genes involved in these processes can impair energy metabolism and lead to disease.

Impaired RNA surveillance and turnover can contribute to neurodegeneration by allowing aberrant RNAs to accumulate. Although direct links for GO:0071040 are still emerging, the broader pathway of poly(A)-dependent decay is relevant to neuronal health.

Altered RNA stability and polyadenylation can affect oncogene and tumor suppressor expression. Understanding antisense transcript catabolism may reveal mechanisms by which cancer cells evade normal RNA quality control.

RNA-seq can quantify antisense transcript levels and identify changes upon perturbation of polyadenylation-dependent decay. Strand-specific libraries are particularly useful for distinguishing sense and antisense RNAs.

Methods such as poly(A) tail length assays can measure the addition of adenines to antisense transcripts. These assays help confirm that a transcript is polyadenylated prior to degradation.

CRISPR knockout, point mutation, knock-in, and overexpression models allow functional testing of candidate genes in this pathway. Library screening can identify novel regulators of antisense transcript catabolism.

Biochemical fractionation and imaging can localize decay factors and antisense transcripts within the nucleus. These approaches complement transcriptomic data.

Researchers studying nuclear polyadenylation-dependent antisense transcript catabolic process-related genes often need to determine whether a candidate gene is causally involved in RNA turnover, and CRISPR-based models provide a direct way to test this. EDITGENE offers a suite of services to support such investigations.

GO:0071040 defines a nuclear quality-control process in which antisense transcripts are polyadenylated and then degraded. This pathway is essential for RNA homeostasis and has implications for mitochondrial function and disease. By combining CRISPR-based models with transcriptomic and biochemical methods, researchers can dissect the factors and mechanisms underlying this process.